This is a preview of subscription content, log in via an institution to check access.
References
Evans DB, Guyatt HL. The cost effectiveness of mass drug therapy for intestinal helminths. PharmacoEconomics 1995 Jul; 8(1): 14–22
Mackenzie CD. Anthelmintic therapy: current approaches and challenges. Curr Op Inf Dis 1993 Dec; 6: 812–23
Bundy DAP. Control of intestinal nematode infections by chemotherapy: mass treatment versus diagnostic screening. Trans R Soc Trop Med Hyg 1990; 84: 622–5
Hall A, Anwar KS, Tomkins AM. Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control. Lancet 1992 May 23; 339: 1253–7
Guyatt HL, Bundy DAP, Evans D. A population dynamic approach to the cost-effectiveness analysis of mass anthelmintic treatment: effects of treatment frequency on Ascaris infection. Trans R Soc Trop Med Hyg 1993 Sep–Oct; 87: 570–5
Guyatt HL, Chan MS, Medley GF, et al. Control of Ascaris infection by chemotherapy: which is the most cost-effective option? Trans R Soc Trop Med Hyg 1995 Jan–Feb; 89: 16–20
Warren KS, Bundy DAP, Anderson RM, et al. Helminth infections. In: Jamison DT, Mosley WH, Measham AR, et al., editors. Disease control priorities in developing countries. Oxford: Oxford University Press, 1993: 131–60
Rights and permissions
About this article
Cite this article
Mass therapy is cost effective for controlling intestinal nematodes. Drugs Ther. Perspect 6, 14–16 (1995). https://doi.org/10.2165/00042310-199506100-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199506100-00006